Literature DB >> 8631811

A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.

T M Jenkins1, A Engelman, R Ghirlando, R Craigie.   

Abstract

Structural studies of human immunodeficiency virus type 1 (HIV-1) integrase have been impeded by the low solubility of the protein. By systematic replacement of hydrophobic residues, we previously identified a single amino acid change (F185K) that dramatically improved the solubility of the catalytic domain of HIV-1 integrase and enabled the structure to be determined by x-ray crystallography. We have introduced the same mutation into full-length HIV-1 integrase. The resulting recombinant protein is soluble and fully active in vitro, whereas, HIV-1 carrying the mutation is replication-defective due to improper virus assembly. Analysis of the recombinant protein by gel filtration and sedimentation equilibrium demonstrate a dimer-tetramer self-association. We find that the regions involved in multimerization map to both the catalytic core and carboxyl-terminal domains. The dramatically improved solubility of this protein make it a good candidate for structural studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631811     DOI: 10.1074/jbc.271.13.7712

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  118 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.

Authors:  J C Chen; J Krucinski; L J Miercke; J S Finer-Moore; A H Tang; A D Leavitt; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Authors:  J Y Wang; H Ling; W Yang; R Craigie
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays.

Authors:  C Laboulais; E Deprez; H Leh; J F Mouscadet; J C Brochon; M Le Bret
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

5.  Solution conformation and dynamics of the HIV-1 integrase core domain.

Authors:  Nicholas C Fitzkee; James E Masse; Yang Shen; David R Davies; Ad Bax
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

6.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Crystal structure of a SeqA-N filament: implications for DNA replication and chromosome organization.

Authors:  Alba Guarné; Therese Brendler; Qinghai Zhao; Rodolfo Ghirlando; Stuart Austin; Wei Yang
Journal:  EMBO J       Date:  2005-03-31       Impact factor: 11.598

9.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

10.  Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication.

Authors:  Frederico Aires da Silva; Min Li; Sylvie Rato; Sara Maia; Rui Malhó; Kylie Warren; David Harrich; Robert Craigie; Carlos Barbas; Joao Goncalves
Journal:  Biotechnol Appl Biochem       Date:  2012-10-10       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.